Session: Moderated Oral ePoster Session 02 - Prostate Cancer - Basic Science and Prostate Cancer - Clinical Localized
MP-21.02: A Single-Arm, Randomized Phase I/iia Trial of the Novel PSMA Targeted Fluorescent Contrast Agent Dgpr1008 for Intraoperative Fluorescence Imaging in Prostate Cancer